World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02335398
Date of registration: 07/01/2015
Prospective Registration: No
Primary sponsor: Mahidol University
Public title: Development and Evaluation of a Methadone Protocol for Severe Chronic Pain Management
Scientific title: Development and Evaluation of a Methadone Protocol for Severe Chronic Pain Management
Date of first enrolment: July 2011
Target sample size: 34
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT02335398
Study type:  Interventional
Study design:  Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 4
Countries of recruitment
Thailand
Contacts
Name:     Phutsadee Pudchakan, Bsc.Pharm
Address: 
Telephone:
Email:
Affiliation:  Thailand: Faculty of Pharmacy, Mahidol University
Name:     Krittika Tanyasaensook, Ph.D.
Address: 
Telephone:
Email:
Affiliation:  Thailand: Faculty of Pharmacy, Mahidol University
Name:     Pongparadee Chaudakshetrin, M.D.
Address: 
Telephone:
Email:
Affiliation:  Thailand: Faculty of Medicine Siriraj Hospital
Name:     Chuthamanee Suthisisang, Ph.D.
Address: 
Telephone:
Email:
Affiliation:  Thailand: Faculty of Pharmacy, Mahidol University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Outpatients aged 18 or over who suffered from severe chronic cancer or noncancer pain
to be firstly treated with methadone as analgesics

Exclusion Criteria:

- QTc interval that was more than 500 msec

- History of opioid addiction

- Having structural heart diseases

- During pregnancy or lactation period

- Patients who have hypersensitivity to methadone



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Pain, Chronic
Intervention(s)
Drug: Methadone
Primary Outcome(s)
Pain score [Time Frame: 3 months]
Secondary Outcome(s)
pain interferences scores [Time Frame: 3 months]
QTc intervals [Time Frame: 3 months]
severity of adverse effects [Time Frame: 3 months]
Neuropathic pain score [Time Frame: 3 months]
Secondary ID(s)
289/2554(EC4)
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history